- Home
- BBIO vs FLS Comparison
BBIO vs FLS Comparison
Compare BBIO & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- FLS
- Stock Information
- Founded
- BBIO 2015
- FLS 1790
- Country
- BBIO United States
- FLS United States
- Employees
- BBIO N/A
- FLS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- FLS Fluid Controls
- Sector
- BBIO Health Care
- FLS Industrials
- Exchange
- BBIO Nasdaq
- FLS Nasdaq
- Market Cap
- BBIO 7.6B
- FLS 8.3B
- IPO Year
- BBIO 2019
- FLS N/A
- Fundamental
- Price
- BBIO $41.73
- FLS $47.35
- Analyst Decision
- BBIO Strong Buy
- FLS Strong Buy
- Analyst Count
- BBIO 13
- FLS 9
- Target Price
- BBIO $56.67
- FLS $64.11
- AVG Volume (30 Days)
- BBIO 2.5M
- FLS 2.5M
- Earning Date
- BBIO 07-31-2025
- FLS 07-28-2025
- Dividend Yield
- BBIO N/A
- FLS 1.84%
- EPS Growth
- BBIO N/A
- FLS 20.22
- EPS
- BBIO N/A
- FLS 2.14
- Revenue
- BBIO $127,415,000.00
- FLS $4,614,870,000.00
- Revenue This Year
- BBIO $102.05
- FLS $7.11
- Revenue Next Year
- BBIO $54.69
- FLS $3.67
- P/E Ratio
- BBIO N/A
- FLS $21.70
- Revenue Growth
- BBIO N/A
- FLS 4.23
- 52 Week Low
- BBIO $21.62
- FLS $37.34
- 52 Week High
- BBIO $41.90
- FLS $65.08
- Technical
- Relative Strength Index (RSI)
- BBIO 69.82
- FLS 45.59
- Support Level
- BBIO $39.65
- FLS $46.28
- Resistance Level
- BBIO $41.36
- FLS $49.58
- Average True Range (ATR)
- BBIO 1.51
- FLS 1.37
- MACD
- BBIO 0.35
- FLS -0.39
- Stochastic Oscillator
- BBIO 97.37
- FLS 21.43
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.